Interestingly, blocking CD47 with monoclonal antibodies inhibited tumor growth and effectively eliminated CSCs through both SIRP-dependent [99, 101, 104] and SIRP-independent mechanisms [107]. The gene discussed is CD47; the disease is neoplasm.